Chapter 3 : Overview of the Parasitic Pathogens

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Overview of the Parasitic Pathogens, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817978/9781555812140_Chap03-1.gif /docserver/preview/fulltext/10.1128/9781555817978/9781555812140_Chap03-2.gif


The genetic and morphologic complexity of parasites makes them challenging targets for immunological studies. The chapter focuses on major parasites and the diseases they cause. infection in humans arises from the consumption of undercooked infected meat or through contact with the feces of an infected cat. The species of that cause disease in humans are, in decreasing order of importance, , , , and . is endemic in sub-Saharan Africa, where it is transmitted between humans by blood-feeding tsetse flies. In humans, trematodes live either within the bloodstream or within the lungs or intestine. The most important cestodes that infect humans are , , and spp. Impaired lymphatic drainage associated with the adult parasites living within the lymph vessels can lead to elephantiasis, a self-explanatory condition in which there is severe swelling of the limb extremities, genitalia, and breasts. The chapter considers few general characteristics of immunity to parasites that deserve special attention, and discusses relationship between immunity and disease. With global warming, there is also an expectation that parasites previously considered to be largely tropical pathogens will move north and south of their traditional areas of endemicity to cause disease in formerly temperate zones. The ready spread of parasitic pathogens is also enhanced by the greater ease of global travel and by the global transportation of food (a factor in outbreaks of foodborne infection in the United States).

Citation: Pearce E, Tarleton R. 2002. Overview of the Parasitic Pathogens, p 39-52. In Kaufmann S, Sher A, Ahmed R (ed), Immunology of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817978.ch3
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Alexander, J.,, and C. A. Hunter. 1998. Immunoregulation during toxoplasmosis. Chem. Immunol. 70: 81 102.
2. Alexander, J.,, A. R. Satoskar,, and D. G. Russell. 1999. Leishmania species: models of intracellular parasitism. J. Cell Sci. 112: 2993 3002.
3. Araujo, M. I.,, E. M. Carvalho,, E. J. Pearce,, and E. A. Sabin. 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173: 269 272.
4. Bancroft, A.,, A. J. Curry,, D. W. Dunne,, K. J. Else,, R. K. Grencis,, and J. Jones. 1995. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J. Exp. Med. 181: 769 774.
5. Bancroft, A. J.,, and R. K. Grencis. 1998. Th1 and Th2 cells and immunity to intestinal helminths. Chem. Immunol. 71: 192 208.
6. Beverley, S. M.,, and S. J. Turco. 1998. Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol. 6: 35 40.
7. Bogdan, C.,, A. Diefenbach,, and M. A. Rollinghoff. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173: 17 26.
8. Bujard, H.,, A. Crisanti,, M. R. Hollingdale,, H. M. Muller,, I. Reckmann,, and K. J. Robson. 1993. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J. 12: 2881 2889.
9. Burleigh, B. A., 2000. Lysosome exocytosis and invasion of nonphagocytic host cells by Trypanosom cruzi, p. 195 212. In C. Tschudi, and E. J. Pearce (ed.), Biology of Parasitism. Kluwer Academic Publishers, Boston, Mass.
10. Butterworth, A. E.,, D. W. Dunne,, A. J. Fulford,, J. H. Ouma,, and R. F. Sturrock. 1996. Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects. Am. J. Trop. Med. Hyg. 55(Suppl.): 109 115.
11. Carruthers, V. B.,, O. K. Giddings,, S. Hakansson,, and L. D. Sibley. 2000a. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect. Immun. 68: 4005 4011.
12. Carruthers, V. B.,, G. D. Sherman,, and L. D. Sibley. 2000b. The Toxoplasma adhesive protein MIC2 is proteolytically processed at multiple sites by two parasite-derived proteases. J. Biol. Chem. 275: 14346 14353.
13. Carter, R.,, K. N. Mendis,, L. H. Miller,, L. Molineaux,, and A. Saul. 2000. Malaria transmission-blocking vaccines—how can their development be supported? Nat. Med. 6: 241 244.
14. Chan, M. S.,, G. F. Medley,, P. Jaimison,, and D. A. P. Bundy. 1994. The evaluation of potential global morbidity attributable to intestinal nematode infections. Parasitology 109: 373 387.
15. Cheever, A. W.,, and G. S. Yap. 1997. Immunologic basis of disease and disease regulation in schistosomiasis. Chem. Immunol. 66: 159 176.
16. Chen, Q.,, M. Wahlgren,, and M. Schlichtherle. 2000. Molecular aspects of severe malaria. Clin. Microbiol. Rev. 13: 439 450.
17. Cooper, P. J.,, I. Espinel,, M. Espinel,, R. H. Guderian,, T. B. Nutman,, W. Paredes,, and M. Wieseman. 1999. Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect. Immun. 67: 5951 5957.
18. Crawford, M. J.,, R. G. Donald,, L. M. Fohl,, K. M. Hager,, J. C. Kissinger,, M. G. Reynolds,, D. S. Roos,, B. Striepen,, and W. J. Sullivan, Jr. 1999. Transport and trafficking: Toxoplasma as a model for Plasmodium. Novartis Found. Symp. 226: 176 195, discussion 195-198.
19. de Almeida, A. B.,, and D. O. Freedman. 1999. Epidemiology and immunopathology of bancroftian filariasis. Microbes Infect. 1: 1015 1022.
20. Dondorp, A. M.,, P. A. Kager J,. Vreeken,, and N. J. White. 2000. Abnormal blood flow and red blood cell deformability in severe malaria. Parasitol. Today 16: 228 232.
21. Donelson, J. E.,, N. M. El-Sayed,, and K. L. Hill. 1998. Multiple mechanisms of immune evasion by African trypanosomes. Mol. Biochem. Parasitol. 91: 51 66.
22. Dunne, D. W.,, and E. J. Pearce. 1999. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect. 17: 553 560.
23. Engwerda, C. R.,, and P. M. Kaye. 2000. Organ-specific immune responses associated with infectious disease. Immunol. Today 21: 73 78.
24. Espinosa-Cantellano, M.,, and A. Martinez-Palomo. 2000. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin. Microbiol. Rev. 13: 318 331.
25. Fowell, D. J.,, and R. M. Locksley. 1999. Leishmania major infection of inbred mice: unmasking genetic determinants of infectious diseases. Bioessays 21: 510 518.
26. Frasch, A. C. 2000. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 16: 282 286.
27. Frevert, U. 1994. Malaria sporozoite-hepatocyte interactions. Exp. Parasitol. 79: 206 210.
28. Gazzinelli, R. T.,, M. Wysocka,, S. Hieny,, T. Scharton-Kersten,, A. Cheever,, R. Kuhn,, W. Muller,, G. Trinchieri,, and A. Sher. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157: 798 805.
29. Gilchrist, C. A.,, and W. A. Petri. 1999. Virulence factors of Entamoeba histolytica Curr. Opin. Microbiol. 2: 433 437.
30. Good, M. F.,, and D. L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11: 412 419.
31. Griffiths, J. K.,, and S. Tzipori. 1998. Natural history and biology of Cryptosporidium parvum. Adv. Parasitol. 40: 5 36.
32. Grzych, J. M.,, E. Pearce,, A. Cheever,, Z. A. Caulada,, P. Caspar,, S. Heiny,, F. Lewis,, and A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146: 1322 1327.
33. Hall, L. R.,, and E. Pearlman. 1999. Pathogenesis of onchocercal keratitis (River blindness). Clin. Microbiol. Rev. 12: 445 453.
34. Hayward, R. E.,, J. L. Derisi,, S. Alfadhli,, D. C. Kaslow,, P. O. Brown,, and P. K. Rathod. 2000. Shotgun DNA microarrays and stage-specific gene expression in Plasmodium falciparum malaria. Mol. Microbiol. 35: 6 14.
35. Hertz, C. J.,, and J. M. Mansfield. 1999. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell Immunol. 192: 24 32.
36. Hoffman, S. L.,, A. A. Mahmoud,, H. W. Murray,, T. B. Nutman,, and J. Pepin. 2000. Tropical medicine. Br. Med. J. 320: 490 494.
37. Hunter, C. A.,, L. A. Ellis-Neyes,, T. Slifer,, S. Kanaly,, G. Grunig,, M. Fort,, D. Rennick,, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311 3316.
38. Huston, C.,, and W. A. Petri, Jr. 1998. Host-pathogen interaction in amebiasis and progress in development. Eur. J. Clin. Microbiol. Infect. Dis. 17: 601 614.
39. Jones, D. E.,, L. U. Buxbaum,, and P. Scott. 2000. IL-4- independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165: 364 372.
40. Kierszenbaum, F. 1999. Chagas’ disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12: 210 223.
41. King, C. L.,, S. Mahanty,, V. Kumaraswami,, J. S. Abrams,, J. Regunathan,, K. Jayaraman,, E. A. Ottesen,, and T. B. Nutman. 1993. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J. Clin. Investig. 92: 1667 1673.
42. Klotz, F. W.,, J. D. Haynes,, and P. A. Orlandi. 1992. A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum, recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A. J. Cell Biol. 116: 901 909.
43. Laclette, J. P.,, C. B. Shoemaker,, D. Richter,, D. L. Arcos,, N. Pante,, C. Cohen,, D. Bing,, and A. Nicholson-Weller. 1992. Paramyosin inhibits complement C1. J. Immunol. 148: 124 128.
44. MacLean, L.,, M. Odiit,, D. Okitoi,, and J. M. Sternberg. 1999. Plasma nitrate and interferon gamma in Trypanosoma brucei rhodesiense infections: evidence that nitric oxide production is induced during both early blood-stage and late meningoencephalitic-stage infections. Trans. R. Soc. Trop. Med. Hyg. 93: 169 170.
45. Manger, I. D.,, and D. A. Relman. 2000. How the host ‘sees’ pathogens: global gene expression responses to infection. Curr. Opin. Immunol. 12: 215 221.
46. McDowell, M. A.,, and D. L. Sacks. 1999. Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses. Curr. Opin. Microbiol. 2: 438 443.
47. Mordue, D. G.,, N. Desai,, M. Dustin,, and L. D. Sibley. 1999. Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring. J. Exp. Med. 190: 1783 1792.
48. Mosser, D. M.,, and C. L. Karp. 1999. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11: 406 411.
49. Murray, H. W.,, J. Pepin,, T. B. Nutman,, S. L. Hoffman,, and A. A. Nahmoud. 2000. Tropical medicine. Br. Med. J. 320: 490 494.
50. Newbold, C. I. 1999. Antigenic variation in Plasmodium falciparum: mechanisms and consequences. Curr. Opin. Microbiol. 2: 420 425.
51. Neyer, L. E.,, G. Grunig,, M. Fort,, J. S. Remington,, D. Rennick,, and C. A. Hunter. 1997. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65: 1675 1682.
52. Ong, R. K.,, and R. L. Doyle. 1998. Tropical pulmonary eosinophilia. Chest 113: 1673 1679.
53. Overath, P.,, and T. Aebischer. 1999. Antigen presentation by macrophages harboring intravesicular pathogens. Parasitol. Today 15: 325 332.
54. Pastrana, D.,, V. N. Raghavan,, P. FitzGerald,, S. W. Eisinger,, C. Metz,, R. Bucala,, R. P. Schleimer,, C. Bickel,, and A. L. Scott. 1998. Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect. Immun. 66: 5955 5963.
55. Perkins, M. E.,, and L. J. Rocco. 1988. Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes. J. Immunol. 141: 3190 3196.
56. Plebanski, M.,, E. A. Lee,, and A. V. Hill. 1997. Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein. Parasitology 115(Suppl.): S55 S66.
57. Reiner, S. L.,, and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151 177.
58. Roos, D.,, J. A., Darling,, K. M. Hager,, J. Kissinger,, M. G. Reynold,, and B. Striepen,. 2000. Toxoplasma as a model apicomplexan parasite: biochemistry, cell biology, molecular genetics, genomics and beyond, p. 143 168. In C. Tschudi, and E. J. Pearce (ed.), Biology of Parasitism. Kluwer Academic Publishers, Boston, Mass.
59. Rosa Brunet, L.,, F. D. Finkelman,, A. W. Cheever,, M. A. Kopf,, and E. J. Pearce. 1997. IL-4 protects against TNF-alphamediated cachexia and death during acute schistosomiasis. J. Immunol. 159: 777 785.
60. Rudenko, G. 1999. Genes involved in phenotypic and antigenic variation in African trypanosomes and malaria. Curr. Opin. Microbiol. 2: 651 656.
61. Sacks, D. L. 1992. The structure and function of the surface lipophosphoglycan on different developmental stages of Leishmania promastigotes. Infect. Agents Dis. 14: 200 206.
62. Seitz, H. M.,, and T. Trammer. 1998. Opportunistic infections caused by protozoan parasites. Tokai J. Exp. Clin. Med. 23: 249 257.
63. Tarleton, R. L., 1996. Immunity to Trypanosoma cruzi, p. 227 247. In S. H. E. Kaufmann (ed.), Host Response to Intracellular Pathogens. R. G. Landes Co., Austin, Tex.
64. Tarleton, R. L.,, M. J. Grusby,, M. Postan,, and L. H. Glimcher. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8: 13 22.
65. Tarleton, R. L.,, and L. Zhang. 1999. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today 15: 94 99.
66. Tarleton R. L.,, M. J. Grusby,, and L. Zhang. 2000. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6- deficient mice to infection with Trypanosoma cruzi. J. Immunol. 165: 1520 1525.
67. Vidal, K.,, and P. M. Allen. 1996. The effect of endogenous altered peptide ligands on peripheral T-cell responses. Semin. Immunol. 8: 117 122.
68. Weiss, L. M.,, and K. Kim. 2000. The development and biology of bradyzoites of Toxoplasma gondii. Front. Biosci. 5: D391 D405.
69. Welsh, R. M.,, and J. M. McNally. 1999. Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections. Curr. Opin. Microbiol. 2: 382 387.
70. White, A. C., Jr.,, P. Robinson,, and R. Kuhn. 1997. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem. Immunol. 66: 209 230.
71. Wilson, M. E.,, B. M. Young,, B. L. Davidson,, K. A. Mente,, and S. E. McGowan. 1998. The importance of TGF-beta in murine visceral leishmaniasis. J. Immunol. 161: 6148 6155.
72. Yap, G. S.,, and A. Sher. 1999. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201: 240 247.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error